These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 3500779
1. Immune response by biological response modifiers. Chirigos MA, Schlick E, Budzynski W. Cancer Detect Prev Suppl; 1987; 1():385-97. PubMed ID: 3500779 [Abstract] [Full Text] [Related]
2. Comparison of in vitro and in vivo modulation of myelopoiesis by biological response modifiers. Schlick E, Hartung K, Chirigos MA. Cancer Immunol Immunother; 1984; 18(3):226-32. PubMed ID: 6334554 [Abstract] [Full Text] [Related]
3. Biological characterization of MVE-2 and poly ICLC. Schlick E, Welker R, Piccoli M, Ruffmann R, Chirigos M. Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902 [No Abstract] [Full Text] [Related]
4. Modulation of myelopoiesis by CSF or CSF-inducing biological response modifiers. Schlick E, Ruffmann R, Hartung K, Chirigos MA. J Immunopharmacol; 1985; 7(1):141-66. PubMed ID: 3874241 [Abstract] [Full Text] [Related]
5. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2. Zhang SR, Salup RR, Urias PE, Twilley TA, Talmadge JE, Herberman RB, Wiltrout RH. Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675 [Abstract] [Full Text] [Related]
10. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide. Schlick E, Ruffmann R, Chirigos MA, Welker RD, Herberman RB. Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661 [Abstract] [Full Text] [Related]
12. Prostaglandin E synthesis and release by murine macrophages and human monocytes after in vitro treatment with biological response modifiers. Hartung K, Schlick E, Stevenson HC, Chirigos MA. J Immunopharmacol; 1983 Mar; 5(3):129-46. PubMed ID: 6197486 [Abstract] [Full Text] [Related]
14. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. Keller JR, Jacobsen SE, Sill KT, Ellingsworth LR, Ruscetti FW. Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7190-4. PubMed ID: 1831268 [Abstract] [Full Text] [Related]
15. Modification of macrophage differentiation: dimethylnitrosamine induced alteration in the responses towards the regulatory signals controlling myelopoiesis. Myers MJ, Schook LB. Int J Immunopharmacol; 1987 Aug 15; 9(7):817-25. PubMed ID: 3323077 [Abstract] [Full Text] [Related]
18. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC. Blood Cells; 1987 Aug 15; 13(1-2):31-48. PubMed ID: 3499193 [Abstract] [Full Text] [Related]
19. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. Broxmeyer HE, Lu L, Cooper S, Tushinski R, Mochizuki D, Rubin BY, Gillis S, Williams DE. J Immunol; 1988 Dec 01; 141(11):3852-62. PubMed ID: 3053902 [Abstract] [Full Text] [Related]
20. Overview of chemicals and biologicals capable of regulating immunity. Chirigos MA. Prog Clin Biol Res; 1984 Dec 01; 161():423-32. PubMed ID: 6207546 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]